相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Population-based analysis of prostate-specific antigen (PSA) screening in younger men (< 55 years) in Australia
Weranja K. B. Ranasinghe et al.
BJU INTERNATIONAL (2014)
The Melbourne Consensus Statement on the early detection of prostate cancer
Declan G. Murphy et al.
BJU INTERNATIONAL (2014)
Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2013)
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Horwich et al.
ANNALS OF ONCOLOGY (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy
Susan Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Screening for prostate cancer in New Zealand general practice
Obertova Zuzana et al.
JOURNAL OF MEDICAL SCREENING (2013)
Prostate-Specific Antigen Screening Trials and Prostate Cancer Deaths: The Androgen Deprivation Connection
Ian E. Haines et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Early Detection of Prostate Cancer: AUA Guideline
H. Ballentine Carter et al.
JOURNAL OF UROLOGY (2013)
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011
Sue M. Evans et al.
MEDICAL JOURNAL OF AUSTRALIA (2013)
The Dilemma of a Rising Prostate-Specific Antigen Level After Local Therapy: What Are Our Options?
Nicholas G. Zaorsky et al.
SEMINARS IN ONCOLOGY (2013)
Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer
Simpa S. Salami et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: Is transrectal ultrasound suitable to determine which patients should undergo active surveillance?
Brian E. Weiss et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
Andrew J. Vickers et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
Virginia A. Moyer
ANNALS OF INTERNAL MEDICINE (2012)
Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer
Andrew J. Armstrong et al.
EUROPEAN UROLOGY (2012)
Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion
Ethan Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
Gerald L. Andriole et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Prostate-Cancer Mortality at 11 Years of Follow-up
Fritz H. Schroder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Radical Prostatectomy versus Observation for Localized Prostate Cancer
Timothy J. Wilt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
Anita V. Mitra et al.
BJU INTERNATIONAL (2011)
Screening for prostate cancer: an updated Cochrane systematic review
Dragan Ilic et al.
BJU INTERNATIONAL (2011)
Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer
Richard Morgan et al.
CLINICAL CANCER RESEARCH (2011)
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
Axel Heidenreich et al.
EUROPEAN UROLOGY (2011)
Prediction Models: Revolutionary in Principle, But Do They Do More Good Than Harm?
Andrew J. Vickers
JOURNAL OF CLINICAL ONCOLOGY (2011)
An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection
Andrew J. Vickers et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
Laurence Klotz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
[-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study
Brian V. Le et al.
JOURNAL OF UROLOGY (2010)
Mortality results from the Goteborg randomised population-based prostate-cancer screening trial
Jonas Hugosson et al.
LANCET ONCOLOGY (2010)
Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials
Mia Djulbegovic et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time As Predictors for Prostate Cancer
Andrew J. Vickers et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy
Bruce J. Trock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the prostate cancer clinical trials working group
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
PCA3: A molecular urine assay for predicting prostate biopsy outcome
Ina L. Deras et al.
JOURNAL OF UROLOGY (2008)
Predicting prostate cancer risk through incorporation of prostate cancer gene 3
Donna Pauler Ankerst et al.
JOURNAL OF UROLOGY (2008)
Recurrent gene fusions in prostate cancer
Chandan Kumar-Sinha et al.
NATURE REVIEWS CANCER (2008)
Trials of decision aids for prostate cancer screening - A systematic review
Robert J. Volk et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2007)
Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer
Andrew J. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years
Hans Lilja et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer
MR Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Screening for prostate cancer in high risk populations
WJ Catalona et al.
JOURNAL OF UROLOGY (2002)
Low levels of prostate-specific antigen predict long-term risk of prostate cancer: Results from the Baltimore Longitudinal Study of Aging
JY Fang et al.
UROLOGY (2001)
分享论文
